DIRS.INFO The most relevant business & tech news

☆ The three-year cruise is canceled
▼ + stars: | 2023-11-24 | by ( Julia Buckley | ) edition.cnn.com time to read: +12 min

But now the dream is over for passengers who’d signed up for Life at Sea Cruises’ inaugural three-year voyage. But on November 17 – less than two weeks before the third departure date – passengers were informed the cruise was off. “In case we weren’t clear, the Life at Sea cruise trip is canceled,” Bayramoglu wrote, giving instructions on the refund process, and how passengers can retrieve “pods” full of their belongings – which they’d shipped in advance of the cruise. If Life at Sea passengers didn’t take up the offer, she said, they’d also be looking to launch a long-term cruise in October 2024. The letter was sent to CNN November 21 and spoke about a potential upcoming cruise date – despite the cruise having already been canceled.

Persons: CNN —, who’d, “, –, ”, AIDA Cruises, Kendra Holmes –, Holmes, Vedat Ugurlu, Ugurlu, Miray, Mikael Petterson, Petterson, Ugurlu’s, Ethem Bayramoglu, ” Bayramoglu, they’d, Bayramoglu, Kendra Holmes, Holmes didn’t, HLC, – I’m Organizations: CNN, Cruises ’, Sea Cruises, Carnival Corp, Celestyal Cruises, Miray, Miray Cruises, Cruises, HLC Cruises, Petterson Locations: Istanbul, Turkey, Amsterdam, Netherlands, Germany, Israel

☆ Temasek-backed firms buy stake in VIVA Biotech unit ahead of listing
▼ + stars: | 2023-06-12 | by ( ) www.reuters.com time to read: +2 min

VIVA Biotech said it will use the net proceeds to redeem convertible bonds in a bid "to settle its outstanding liabilities without occupying its internal resources." The deal included capital injection into VIVA Shanghai by new investors and sale of existing interest in VIVA Shanghai from Viva Investment, another unit of VIVA Biotech, the filing showed. Ltd, will altogether hold 17.55% stake in VIVA Shanghai after the deal, according the filing. HLC SPV and Qingdao Hongyi, both linked to HighLight Capital, will obtain a total of 6.66% stake from the transaction. VIVA Biotech has initiated a restructuring which will transfer all assets and personnel related to its early-stage drug discovery business to VIVA Shanghai, and move out of the Shanghai unit any assets and personnel related to drug development and manufacturing service, the filing showed.

Persons: Roxanne Liu, Kane Wu, Stephen Coates Organizations: Singapore's Temasek, Capital, VIVA Biotech Holdings, HK, VIVA, VIVA Shanghai, VIVA Biotech, Viva Investment, Daxue Investments, Temasek Holdings, Temasek, Ltd, SPV, Qingdao Hongyi, Investors, Thomson Locations: Shanghai, Viva

Search resuls for: "HLC"

2 mentions found